EUCROSS: A European Phase II Trial of Crizotinib in Advanced Adenocarcinoma of the Lung Harboring ROS1 Rearrangements - Preliminary Results

被引：14

作者：

Michels, Sebastian ^{[1
]}

Gardizi, Masyar ^{[1
]}

Schmalz, Petra ^{[2
]}

Thurat, Meike ^{[1
]}

Pereira, Eva ^{[3
]}

Sebastian, Martin ^{[4
]}

Carcereny, Enric ^{[5
]}

Corral, Jesus ^{[6
]}

Paz-Ares, Luis ^{[6
]}

Felip, Enriqueta ^{[7
]}

Grohe, Christian ^{[8
]}

Rodriguez Abreu, Delvys ^{[9
]}

Insa Molla, Amelia ^{[10
]}

Bischoff, Helge ^{[11
]}

Reck, Martin ^{[12
]}

Karachaliou, Niki ^{[13
,14
]}

Scheel, Andreas ^{[15
]}

Brandes, Vanessa ^{[1
]}

Rieke, Fischer ^{[1
]}

Nogova, Lucia ^{[1
]}

Scheffler, Matthias ^{[1
]}

Franklin, Jeremy ^{[16
]}

Hellmich, Martin ^{[16
]}

Massuti, Bartomeu ^{[17
]}

Buettner, Reinhard ^{[15
]}

Rosell, Rafael ^{[18
]}

Wolf, Juergen ^{[1
]}

机构：

[1] Univ Hosp Cologne, Lung Canc Grp Cologne, Cologne, Germany

[2] Clin Trial Ctr Cologne, Cologne, Germany

[3] Spanish Lung Canc Grp, Barcelona, Spain

[4] Univ Klin Frankfurt Main, Frankfurt, Germany

[5] Hosp Badalona Germans Trias & Pujol, Catalan Inst Oncol, Med Oncol, Badalona, Spain

[6] Hosp Univ Virgen Del Rocio, Seville, Spain

[7] Vall DHebron Univ Hosp, Barcelona, Spain

[8] Evangel Lungenklin, Berlin, Germany

[9] Univ Hosp Maternoinfantil Canarias, Las Palmas Gran Canaria, Spain

[10] Univ Hosp Clin Valencia, Med Oncol, Valencia, Spain

[11] Thoraxklin Heidelberg, Heidelberg, Germany

[12] Lungclin Grosshansdorf, Grosshansdorf, Germany

[13] Hosp Sagrat Cor, Barcelona, Spain

[14] Germans Trias & Pujol Hlth Sci Inst & Hosp, Barcelona, Spain

[15] Univ Hosp Cologne, Inst Pathol, Cologne, Germany

[16] Univ Hosp Cologne, Inst Med Stat Informat & Epidemiol, Cologne, Germany

[17] Alicante Univ Hosp, Med Oncol, Alicante, Spain

[18] Hosp Badalona Germans Trias & Pujol, Catalan Inst Oncol, Barcelona, Spain

来源：

JOURNAL OF THORACIC ONCOLOGY | 2017年 / 12卷 / 01期

关键词：

NSCLC; crizotinib; ros1;

D O I：

10.1016/j.jtho.2016.11.428

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

MA07.05

引用

页码：S379 / S380

页数：2

共 50 条

[1] Safety and Efficacy of Crizotinib in Patients With Advanced or Metastatic ROS1-Rearranged Lung Cancer (EUCROSS): A European Phase II Clinical Trial
Michels, Sebastian
Massuti, Bartomeu
Schildhaus, Hans-Ulrich
Franklin, Jeremy
Sebastian, Martin
Felip, Enriqueta
Grohe, Christian
Rodriguez-Abreu, Delvys
Abdulla, Diana S. Y.
Bischoff, Helge
Brandts, Christian
Carcereny, Enric
Corral, Jesus
Dingemans, Anne-Marie C.
Pereira, Eva
Fassunke, Jana
Fischer, Rieke N.
Gardizi, Masyar
Heukamp, Lukas
Insa, Amelia
Kron, Anna
Menon, Roopika
Persigehl, Thorsten
Reck, Martin
Riedel, Richard
Rothschild, Sacha I.
Scheel, Andreas H.
Scheffler, Matthias
Schmalz, Petra
Smit, Egbert F.
Limburg, Meike
Provencio, Mariano
Karachaliou, Niki
Merkelbach-Bruse, Sabine
Hellmich, Martin
Nogova, Lucia
Buettner, Reinhard
Rosell, Rafael
Wolf, Juergen
JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (07) : 1266 - 1276
[2] Crizotinib in Patients with ROS1 NSCLC. Preliminary Results of the AcSe Trial
Moro-Sibilot, Denis
Faivre, Laura
Zalcman, Gerard
Perol, Maurice
Mazieres, Julien
Barlesi, Fabrice
Otto, Josiane
Monnet, Isabelle
Cortot, Alexis
Wislez, Marie
Lena, Herve
Souquet, Pierre Jean
Lantuejoul, Sylvie
Rouquette, Isabelle
Mcleer-Florin, Anne
Ferretti, Gilbert
Hoog-Labouret, Natalie
Nowak, Freferique
Jimenez, Marta
Vassal, Gilles
JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S374 - S374
[3] Overall survival and central nervous system activity of crizotinib in ROS1-rearranged lung cancerdfinal results of the EUCROSS trial
Michels, S.
Massuti, B.
Vasyliv, I.
Stratmann, J.
Frank, J.
Adams, A.
Felip, E.
Grohe, C.
Rodriguez-Abreu, D.
Bischoff, H.
Costa, E. Carcereny i
Pereira, E.
Corral, J.
Fassunke, J.
Fischer, R. N.
Insa, A.
Koleczko, S.
Nogova, L.
Reck, M.
Reutter, T.
Riedel, R.
Schau, D.
Schefler, M.
Weisthoff, M.
Provencio, M.
Merkelbach-Bruse, S.
Hellmich, M.
Sebastian, M.
Buettner, R.
Roseli, R.
Persigehl, T.
Wolf, J.
ESMO OPEN, 2024, 9 (02)
[4] CLINICAL ACTIVITY OF CRIZOTINIB IN PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER HARBORING THE ROS1 GENE REARRANGEMENT
Ou, Sai-hong I.
Bang, Y-j
Camidge, D. R.
Engelman, J. A.
Clark, J. W.
Tye, L.
Wilner, Keith
Stephenson, P.
Chung, D. H.
Varella-Garcia, M.
Iafrate, A. J.
Shaw, A. T.
JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (11) : S455 - S455
[5] Crizotinib in ROS1 Rearranged or MET Deregulated Non-Small-Cell Lung Cancer (NSCLC): Preliminary Results of the METROS Trial
Landi, Lorenza
Chella, Antonio
Chiari, Rita
Tiseo, Marcello
Buosi, Roberta
Dazzi, Claudio
Gridelli, Cesare
Barbieri, Fausto
Delmonte, Angelo
Ali, Greta
Fontanini, Gabriella
Crino, Lucio
Cappuzzo, Frederico
JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S380 - S381
[6] Activity of Crizotinib in MET or ROS1 Positive (+) NSCLC: Results of the AcSe Trial
Moro-Sibilot, D.
Cozic, N.
Perol, M.
Otto, J.
Mazieres, J.
Souquet, P.
Bahleda, R.
Wislez, M.
De Guibert, S.
Mennecier, B.
Chouaid, C.
Sabatier, R.
Bota, S.
Gervais, R.
Verriele, V.
Haddad, V.
Ferretti, G.
Nowak, F.
Oukhatar, C. Mahier-Ait
Vassal, G.
JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S348 - S348
[7] ROS1 rearrangements in lung adenocarcinoma: prognostic impact, therapeutic options and genetic variability
Scheffler, Matthias
Schultheis, Anne
Teixido, Cristina
Michels, Sebastian
Morales-Espinosa, Daniela
Viteri, Santiago
Hartmann, Wolfgang
Merkelbach-Bruse, Sabine
Fischer, Rieke
Schildhaus, Hans-Ulrich
Fassunke, Jana
Sebastian, Martin
Serke, Monika
Kaminsky, Britta
Randerath, Winfried
Gerigk, Ulrich
Ko, Yon-Dschun
Krueger, Stefan
Schnell, Roland
Rothe, Achim
Kropf-Sanchen, Cornelia
Heukamp, Lukas
Rosell, Rafael
Buettner, Reinhard
Wolf, Juergen
ONCOTARGET, 2015, 6 (12) : 10577 - 10585
[8] Unecritinib in Patients with ROS1 Positive Advanced Non-Small Cell Lung Cancer: Updated Results from a Phase II Trial
Lu, S.
Pan, H.
Wu, L.
Yao, Y.
He, J.
Wang, Y.
Wang, X.
Fang, Y.
Zhou, Z.
Wang, X.
Cai, X.
Yu, Y.
Ma, Z.
Min, X.
Yang, Z.
Cao, L.
Yang, H.
Shu, Y.
Zhuang, W.
Cang, S.
Fang, J.
Li, K.
Yu, Z.
Cui, J.
Zhang, Y.
Li, M.
Wen, X.
Zhang, J.
Li, W.
Shi, J.
Xu, X.
Zhong, D.
Li, Z.
JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (10) : S73 - S74
[9] From genotype to phenotype: Are there imaging characteristics associated with lung adenocarcinomas harboring RET and ROS1 rearrangements?
Plodkowski, Andrew J.
Drilon, Alexander
Halpenny, Darragh F.
O'Driscoll, Dearbhail
Blair, Donald
Litvak, Anya M.
Zheng, Junting
Moskowitz, Chaya S.
Ginsberg, Michelle S.
LUNG CANCER, 2015, 90 (02) : 321 - 325
[10] Intestinal metastasis from primary ROS1 -positive lung adenocarcinoma cancer patients responding to crizotinib
Chen, Hua-fei
Zhang, Qu-xia
Zhu, You-cai
Du, Kai-qi
Li, Xiao-feng
Wu, Li-xin
Wang, Wen-xian
Xu, Chun-wei
ONCOTARGETS AND THERAPY, 2018, 11 : 7821 - 7825

← 1 2 3 4 5 →